Adjuvant Chemotherapy in Colon and Gastric Cancer

  • J. S. Macdonald
  • D. G. Haller
  • D. L. Kisner
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 80)


The adjuvant chemotherapy of colorectal and gastric cancer is being actively investigated. Studies of both single antineoplastic agents and combinations of several drugs have been used. In colorectal cancer, single-agent therapy has not resulted in improved survival. Combination chemotherapy studies are at too early a stage to be evaluated. In gastric cancer, single-agent chemotherapy has not been effective as adjunctive treatment to surgery. Combinations of active agents in gastric cancer hold promise as effective surgical adjuvant therapy.


Gastric Cancer Colorectal Cancer Colon Cancer Adjuvant Chemotherapy Advanced Gastric Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Comis RL, Carter SK (1974) Integration of chemotherapy into combined modality treatment of solid tumors. III. Cancer Treat Rep 63:1863–1868Google Scholar
  2. 2.
    Dixon WJ, Longmire P, Holden WD (1971) Use of triethylene-thiophosphoramide as an adjuvant to the surgical treatment of gastric and colorectal cancer. Ten-year follow-up. Ann Surg 173:16–34CrossRefGoogle Scholar
  3. 3.
    Dwight RW, Higgins GA, Keehn RJ (1973) Factors influencing survival after resection in cancer of the colon and rectum. Am J Surg Oncol 5:243–254CrossRefGoogle Scholar
  4. 4.
    Dwight RW, Humphrey EW, Higgins GA (1973) FUDR as an adjuvant to surgery in cancer of the large bowel. J Surg Oncol 5: 243–249PubMedCrossRefGoogle Scholar
  5. 5.
    Frank W, Osterberg AE (1960) Mitomycin-C (NSC 26989). An evaluation of the Japanese reports. Cancer Chemother Rep 9:114–120PubMedGoogle Scholar
  6. 6.
    Grage TB, Hill GJ, Cornell GN, Frelick RW, Moss SE (1979) Adjuvant chemotherapy in large bowel cancer: Updated analysis of single-agent chemotherapy. In: Jones SE, Salmon SG (eds) Adjuvant therapy of cancer II. Grune & Stratton, New York, pp 587–594Google Scholar
  7. 7.
    Higgins GA, Serlin O, Amadeo JH, McElhinney J, Keehn J (1976) Gastric cancer factors in survival. Gastroenterol Surg 10:393–399Google Scholar
  8. 8.
    Higgins GA, Lee LE, Dwight RW, Keehn RJ (1978) The case for adjuvant 5-fluorouracil in colorectal cancer. Cancer Clin Trials 1:35–41Google Scholar
  9. 9.
    Kovach JS, Moertel CG, Schutt AJ (1974) A controlled study of combined l,3-bis(2-chloro- ethyl)-l-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer. Cancer 33:563–569PubMedCrossRefGoogle Scholar
  10. 10.
    Koyama Y, Kimura T (1978) Preventive chemotherapy after radical operations in stomach cancer. In: Thatcher N (ed) Digestive cancer. Pergamon Press, Oxford (Advances in medical oncology. Research and education, vol IX, pp 255–268)Google Scholar
  11. 11.
    Macdonald JS, Schein P, Ueno W, Woolley P (1979) 5-Fluorouracil, mitomycin-C and adriamycin (FAM): A new combination chemotherapy program for advanced gastric carcinoma. Cancer 44:42–47PubMedCrossRefGoogle Scholar
  12. 12.
    Moertel CG (1973) Large bowel. In: Holland JF, Frei E III (eds) Cancer medicine. Lea & Febiger, Philadelphia, pp 1597–1627Google Scholar
  13. 13.
    Moertel CG, Lavin PT (1979) Phase II—III chemotherapy studies in advanced gastric cancer. Cancer Treat Rep 63:1863–1868PubMedGoogle Scholar
  14. 14.
    Moertel CG, Mittelman JA, Bakermeier RF, Engstrom P, Hanely J (1976) Sequential and combination chemotherapy of advanced gastric cancer. Cancer 38:678–684PubMedCrossRefGoogle Scholar
  15. 15.
    Piper DW (1978) Stomach cancer. UICC Tech Rep Ser 34:3–26Google Scholar
  16. 16.
    Serlin O, Wolkoff JS, Amadeo JM, Keehn RJ (1969) Use of 5-fluorodeoxyuridine (FUDR) as an adjuvant to the surgical management of carcinoma of the stomach. Cancer 24:223–230PubMedCrossRefGoogle Scholar
  17. 17.
    Serlin O, Keehn RJ, Higgins GA, Harrower HW, Mendeloff GL (1977) Factors related to survival following resection for gastric carcinoma. Cancer 40:1318–1326PubMedCrossRefGoogle Scholar
  18. 18.
    Silverberg E (1980) Cancer statistics 1980. CA 30:23–38Google Scholar
  19. 19.
    Taylor I, Brooman P, Rowling JT (1977) Adjuvant liver perfusion in colorectal cancer: Initial results of a clinical trial. Br Med J 2:1320–1322PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1982

Authors and Affiliations

  • J. S. Macdonald
    • 1
  • D. G. Haller
    • 1
  • D. L. Kisner
    • 1
  1. 1.Division of Cancer Treatment, Cancer Therapy Evaluation ProgramNational Cancer InstituteBethesdaUSA

Personalised recommendations